-
1
-
-
77951009069
-
Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in Ontario, Canada, 1996 to 2007: A population-based study
-
Gershon AS, Wang C, Wilton AS, Raut R, To T. Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in Ontario, Canada, 1996 to 2007: a population-based study. Arch Intern Med. 2010;170(6):560-565.
-
(2010)
Arch Intern Med
, vol.170
, Issue.6
, pp. 560-565
-
-
Gershon, A.S.1
Wang, C.2
Wilton, A.S.3
Raut, R.4
To, T.5
-
2
-
-
0034055236
-
A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease
-
The Dutch Tiotropium Study Group
-
van Noord JA, Bantje TA, Eland ME, Korducki L, Cornelissen PJ; The Dutch Tiotropium Study Group. A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease. Thorax. 2000;55(4):289-294.
-
(2000)
Thorax
, vol.55
, Issue.4
, pp. 289-294
-
-
van Noord, J.A.1
Bantje, T.A.2
Eland, M.E.3
Korducki, L.4
Cornelissen, P.J.5
-
3
-
-
0027962628
-
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: The Lung Health Study
-
Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study. JAMA. 1994;272(19):1497-1505.
-
(1994)
JAMA
, vol.272
, Issue.19
, pp. 1497-1505
-
-
Anthonisen, N.R.1
Connett, J.E.2
Kiley, J.P.3
-
4
-
-
0027509977
-
Muscarinic receptor subtypes in airways
-
Barnes PJ. Muscarinic receptor subtypes in airways. Life Sci. 1993;52(5-6):521-527.
-
(1993)
Life Sci
, vol.52
, Issue.5-6
, pp. 521-527
-
-
Barnes, P.J.1
-
5
-
-
53749102775
-
A 4-year trial of tiotropium in chronic obstructive pulmonary disease
-
UPLIFT Study Investigators
-
Tashkin DP, Celli B, Senn S, et al; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359 (15):1543-1554.
-
(2008)
N Engl J Med
, vol.359
, Issue.15
, pp. 1543-1554
-
-
Tashkin, D.P.1
Celli, B.2
Senn, S.3
-
6
-
-
79957579403
-
-
Boehringer Ingelheim, Accessed June 10
-
Boehringer Ingelheim. Annual report 2009: value through innovation. http://www.boehringer-ingelheim.com/content/dam/internet/opu/com_EN/document/01_news/04_Annual_Report/AR_2009_english.pdf. Accessed June 10, 2010.
-
(2010)
Annual report 2009: Value through innovation
-
-
-
7
-
-
42449086809
-
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease-2008 update: Highlights for primary care
-
O'Donnell DE, Hernandez P, Kaplan A, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease-2008 update: highlights for primary care. Can Respir J. 2008;15(suppl A):1A-8A.
-
(2008)
Can Respir J
, vol.15
, Issue.SUPPL. A
-
-
O'Donnell, D.E.1
Hernandez, P.2
Kaplan, A.3
-
8
-
-
1842552109
-
Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper
-
[published correction appears in Eur Respir J. 2006;27(1):242], ATS/ERS Task Force
-
Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper [published correction appears in Eur Respir J. 2006;27(1):242]. Eur Respir J. 2004; 23(6):932-946.
-
(2004)
Eur Respir J
, vol.23
, Issue.6
, pp. 932-946
-
-
Celli, B.R.1
McNee, W.2
-
9
-
-
20544450400
-
-
American Thoracic Society and European Respiratory Society, Accessed March 10, 2011
-
American Thoracic Society and European Respiratory Society. Standards for the diagnosis and management of patients with COPD. 2004. http://www.thoracic.org/clinical/copd-guidelines/resources/copddoc.pdf. Accessed March 10, 2011.
-
(2004)
Standards for the diagnosis and management of patients with COPD
-
-
-
10
-
-
56949094751
-
Tiotropium does not affect lower urinary tract functions in COPD patients with benign prostatic hyperplasia
-
Miyazaki H, Suda T, Otsuka A, et al. Tiotropium does not affect lower urinary tract functions in COPD patients with benign prostatic hyperplasia. Pulm Pharmacol Ther. 2008;21(6):879-883.
-
(2008)
Pulm Pharmacol Ther
, vol.21
, Issue.6
, pp. 879-883
-
-
Miyazaki, H.1
Suda, T.2
Otsuka, A.3
-
11
-
-
79954486779
-
Inhaled anticholinergic drugs and risk of acute urinary retention
-
[published online ahead of print September 29, 2010], doi:10.1111/j.1464-410X2010.09600.x
-
Afonso AS, Verhamme KM, Stricker BH, Sturkenboom MC, Brusselle GG. Inhaled anticholinergic drugs and risk of acute urinary retention [published online ahead of print September 29, 2010]. BJU Int. doi:10.1111/j.1464-410X2010.09600.x.
-
BJU Int
-
-
Afonso, A.S.1
Verhamme, K.M.2
Stricker, B.H.3
Sturkenboom, M.C.4
Brusselle, G.G.5
-
12
-
-
0026044501
-
Urinary retention associated with ipratropium bromide
-
Pras E, Stienlauf S, Pinkhas J, Sidi Y. Urinary retention associated with ipratropium bromide. DICP. 1991;25(9):939-940.
-
(1991)
DICP
, vol.25
, Issue.9
, pp. 939-940
-
-
Pras, E.1
Stienlauf, S.2
Pinkhas, J.3
Sidi, Y.4
-
13
-
-
33845938174
-
Pooled clinical trial analysis of tiotropium safety
-
Kesten S, Jara M, Wentworth C, Lanes S. Pooled clinical trial analysis of tiotropium safety. Chest. 2006;130(6):1695-1703.
-
(2006)
Chest
, vol.130
, Issue.6
, pp. 1695-1703
-
-
Kesten, S.1
Jara, M.2
Wentworth, C.3
Lanes, S.4
-
14
-
-
58249106770
-
Tiotropium in chronic obstructive pulmonary disease
-
Singh S, Furberg CD, Loke YK. Tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2009;360(2):186-187.
-
(2009)
N Engl J Med
, vol.360
, Issue.2
, pp. 186-187
-
-
Singh, S.1
Furberg, C.D.2
Loke, Y.K.3
-
15
-
-
42449098439
-
Drug-induced urinary retention: Incidence, management and prevention
-
Verhamme KM, Sturkenboom MC, Stricker BH, Bosch R. Drug-induced urinary retention: incidence, management and prevention. Drug Saf. 2008;31(5):373-388.
-
(2008)
Drug Saf
, vol.31
, Issue.5
, pp. 373-388
-
-
Verhamme, K.M.1
Sturkenboom, M.C.2
Stricker, B.H.3
Bosch, R.4
-
16
-
-
33744529856
-
Incidence of primary and recurrent acute urinary retention between 1998 and 2003 in England
-
Cathcart P, van der Meulen J, Armitage J, EmbertonM. Incidence of primary and recurrent acute urinary retention between 1998 and 2003 in England. J Urol. 2006; 176(1):200-204.
-
(2006)
J Urol
, vol.176
, Issue.1
, pp. 200-204
-
-
Cathcart, P.1
van der Meulen, J.2
Armitage, J.3
Emberton, M.4
-
17
-
-
37249079601
-
Mortality in men admitted to hospital with acute urinary retention: Database analysis
-
Armitage JN, Sibanda N, Cathcart PJ, Emberton M, van der Meulen JH. Mortality in men admitted to hospital with acute urinary retention: database analysis. BMJ. 2007;335(7631):1199-1202.
-
(2007)
BMJ
, vol.335
, Issue.7631
, pp. 1199-1202
-
-
Armitage, J.N.1
Sibanda, N.2
Cathcart, P.J.3
Emberton, M.4
van der Meulen, J.H.5
-
18
-
-
70350096410
-
Identifying individuals with physician diagnosed COPD in health administrative databases
-
Gershon AS, Wang C, Guan J, Vasilevska-Ristovska J, Cicutto L, To T. Identifying individuals with physician diagnosed COPD in health administrative databases. COPD. 2009;6(5):388-394.
-
(2009)
COPD
, vol.6
, Issue.5
, pp. 388-394
-
-
Gershon, A.S.1
Wang, C.2
Guan, J.3
Vasilevska-Ristovska, J.4
Cicutto, L.5
To, T.6
-
19
-
-
0038397012
-
Coding accuracy of administrative drug claims in the Ontario Drug Benefit database
-
Levy AR, O'Brien BJ, Sellors C, Grootendorst P, Willison D. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol. 2003;10(2):67-71.
-
(2003)
Can J Clin Pharmacol
, vol.10
, Issue.2
, pp. 67-71
-
-
Levy, A.R.1
O'Brien, B.J.2
Sellors, C.3
Grootendorst, P.4
Willison, D.5
-
20
-
-
0036515623
-
Diabetes in Ontario: Determination of prevalence and incidence using a validated administrative data algorithm
-
Hux JE, Ivis F, Flintoft V, Bica A. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care. 2002;25(3):512-516.
-
(2002)
Diabetes Care
, vol.25
, Issue.3
, pp. 512-516
-
-
Hux, J.E.1
Ivis, F.2
Flintoft, V.3
Bica, A.4
-
21
-
-
23044451172
-
Nonsteroidal antiinflammatory drugs and increased risk of acute urinary retention
-
Verhamme KM, Dieleman JP, Van Wijk MA, et al. Nonsteroidal antiinflammatory drugs and increased risk of acute urinary retention. Arch Intern Med. 2005;165(13):1547-1551.
-
(2005)
Arch Intern Med
, vol.165
, Issue.13
, pp. 1547-1551
-
-
Verhamme, K.M.1
Dieleman, J.P.2
van Wijk, M.A.3
-
22
-
-
33750364917
-
Acute urinary retention: Risks and management
-
Roehrborn CG. Acute urinary retention: risks and management. Rev Urol. 2005; 7(suppl 4):S31-S41.
-
(2005)
Rev Urol
, vol.7
, Issue.SUPPL. 4
-
-
Roehrborn, C.G.1
-
23
-
-
0026639706
-
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
-
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
-
(1992)
J Clin Epidemiol
, vol.45
, Issue.6
, pp. 613-619
-
-
Deyo, R.A.1
Cherkin, D.C.2
Ciol, M.A.3
-
24
-
-
33750720279
-
The Anticholinergic Drug Scale as ameasure of drug-related anticholinergic burden: Associations with serum anticholinergic activity
-
Carnahan RM, Lund BC, Perry PJ, Pollock BG, Culp KR. The Anticholinergic Drug Scale as ameasure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol. 2006;46(12):1481-1486.
-
(2006)
J Clin Pharmacol
, vol.46
, Issue.12
, pp. 1481-1486
-
-
Carnahan, R.M.1
Lund, B.C.2
Perry, P.J.3
Pollock, B.G.4
Culp, K.R.5
-
25
-
-
0034920302
-
Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients
-
Han L, McCusker J, Cole M, Abrahamowicz M, Primeau F, Elie M. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med. 2001;161(8):1099-1105.
-
(2001)
Arch Intern Med
, vol.161
, Issue.8
, pp. 1099-1105
-
-
Han, L.1
McCusker, J.2
Cole, M.3
Abrahamowicz, M.4
Primeau, F.5
Elie, M.6
-
26
-
-
0034685273
-
Expressing the magnitude of adverse effects in casecontrol studies: "the number of patients needed to be treated for one additional patient to be harmed"
-
Bjerre LM, LeLorier J. Expressing the magnitude of adverse effects in casecontrol studies: "the number of patients needed to be treated for one additional patient to be harmed. " BMJ. 2000;320(7233):503-506.
-
(2000)
BMJ
, vol.320
, Issue.7233
, pp. 503-506
-
-
Bjerre, L.M.1
LeLorier, J.2
-
27
-
-
0023158852
-
Acute urinary retention in women: A prospective study of 18 consecutive cases
-
Klarskov P, Andersen JT, Asmussen CF, et al. Acute urinary retention in women: a prospective study of 18 consecutive cases. Scand J Urol Nephrol. 1987;21 (1):29-31.
-
(1987)
Scand J Urol Nephrol
, vol.21
, Issue.1
, pp. 29-31
-
-
Klarskov, P.1
Andersen, J.T.2
Asmussen, C.F.3
|